You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
For the main assessment we will need a collection of Illumina and Nanopore data with phenotypes.
So far, I have collated accessions for 44,880 Illumina isolates with the following phenotype information
In terms of gathering Nanopore data, a main question is whether we want to only used Nanopore data basecalled with the same version of guppy or not? This is an overarching question for the field too I guess. I am inclined to think the version doesn't matter for this kind of benchmark - provided it was basecalled with guppy. Thoughts?
One last question is whether we want to use all of the 43K Illumina isolates or just a subset based on phenotypes for certain drugs?
The text was updated successfully, but these errors were encountered:
For the main assessment we will need a collection of Illumina and Nanopore data with phenotypes.
So far, I have collated accessions for 44,880 Illumina isolates with the following phenotype information
In terms of gathering Nanopore data, a main question is whether we want to only used Nanopore data basecalled with the same version of guppy or not? This is an overarching question for the field too I guess. I am inclined to think the version doesn't matter for this kind of benchmark - provided it was basecalled with guppy. Thoughts?
One last question is whether we want to use all of the 43K Illumina isolates or just a subset based on phenotypes for certain drugs?
The text was updated successfully, but these errors were encountered: